A complete qPCR kit for the detection of Class A beta-lactamase (KPC) Resistance
KPC (Class A Beta-Lactamase) resistance is a major concern in the healthcare sector, especially in hospital-acquired infections. It is caused by the production of enzymes that can hydrolyze beta-lactam antibiotics, rendering them ineffective. Failure to detect KPC early can lead to treatment failures, prolonged hospital stays, and increased healthcare costs. Syndromic diseases associated with KPC resistance include various types of bacterial infections in both humans and animals.
YouSeq's qPCR kit to detect KPC allows for fast and accurate identification of this antibiotic resistance marker. By detecting KPC early, clinicians can make informed decisions on the appropriate antibiotic therapy, which can lead to better patient outcomes, reduced spread of resistant strains, and overall improved healthcare management.
Available for delivery in United States
Price on enquiry
Order nowFor Research Use Only. Not intended for diagnostic use.
Contents
Technical specification
Product variants
Pseudonyms
Klebsiella pneumoniae carbapenemase; KPC; Carbapenem-resistant Enterobacteriaceae; CRE; Superbug; Multi-drug resistant bacteria; Carbapenemase-producing organism; CPO; Beta-lactamase-mediated resistance; ESBL; Extended-spectrum beta-lactamaseRelated products
Still scrolling? We love adventurers
We work at the cutting edge of molecular biology, striving to disrupt our industry. We drive continuous product innovation and we aren’t afraid to take on new challenges.
More about usRelated learning resources